Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1060 results about "Transaminase" patented technology

Transaminases or aminotransferases are enzymes that catalyze a transamination reaction between an amino acid and an α-keto acid. They are important in the synthesis of amino acids, which form proteins.

Producing optically active amino compounds

InactiveUS7169592B2Efficient and inexpensiveSuitable for useSugar derivativesBacteriaMicroorganismNucleotide
To provide a method for preparing optically active compounds, which mainly contain (R)-amino compounds, by microbial enzymes efficiently and inexpensively; a polypeptide having stereoselective transaminase activity which can be suitably used for the above preparation method; and a DNA encoding the polypeptide. A method for preparing an optically active amino compound, characterized in stereoselectively transaminating by acting a transaminase on an amino group acceptor, a ketone compound in the presence of an amino group donor, a primary amine; a DNA comprising a nucleotide sequence encoding a polypeptide having stereoselective transaminase activity; and a polypeptide having stereoselective transaminase activity obtainable from a culture of a microorganism belonging to the genus Arthrobacter.
Producing optically active amino compounds
Producing optically active amino compounds
Producing optically active amino compounds
View all
Owner:KANEKA CORP

Method for preparing L-glufosinate-ammonium by use of amino acid dehydrogenase

ActiveCN106978453AImprove conversion rateHigh yieldFermentationGlufosinate-ammoniumButyric acid
The invention discloses a method for preparing L-glufosinate-ammonium by use of amino acid dehydrogenase. The method comprises the following steps: taking 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid or a salt thereof as a substrate, taking a cell of the isolated glutamate dehydrogenase or in vitro expression glutamate dehydrogenase as a catalyst to perform reductive amination reaction under the condition of the existence of inorganic amino donor and reduced coenzyme, thereby acquiring the L-glufosinate-ammonium. The method disclosed by the invention is high in raw material conversion rate and high in yield, the product is easy to separate and purify, and the chirality purity is high; compared with the transaminase and like catalysis technology, the process is relatively simple, and the raw material conversion rate reaches up to 100%.
Method for preparing L-glufosinate-ammonium by use of amino acid dehydrogenase
Method for preparing L-glufosinate-ammonium by use of amino acid dehydrogenase
Method for preparing L-glufosinate-ammonium by use of amino acid dehydrogenase
View all
Owner:ZHEJIANG UNIV

Increased production of isobutanol in yeast with reduced mitochondrial amino acid biosynthesis

ActiveUS8465964B2Reduced activityCarbon-nitrogen lyasesMicroorganismsIsobutanolBranched-chain-amino-acid transaminase
Increased production of isobutanol in yeast with reduced mitochondrial amino acid biosynthesis
View all
Owner:GEVO INC

Production method of L-glufosinate

ActiveCN105603015AImprove conversion rateSimple separation processTransferasesMicroorganism based processesButyric acidHydroxy compound
The invention discloses a production method of L-glufosinate. The method includes the steps that with 2-carbonyl-4-(hydroxyl methyl phosphoryl) butyric acid and salt thereof being a substrate, isolated transaminase or a cell catalysis substrate of in-vitro expression transaminase reacts with an amino donor under the condition that the amino donor exists, so that L-glufosinate is obtained, wherein the amino donor is alanine, and the amino acid sequence of transaminase is shown in SEQ ID NO.1-3. With 2-carbonyl-4-(hydroxyl methyl phosphoryl) butyric acid and salt thereof being the substrate and alanine being the amino donor, the transamination reaction occurs through the specific transaminase catalysis substrate, the substrate can be completely converted into L-glufosinate, and the conversion rate of raw materials is high and can reach 100%.
Production method of L-glufosinate
Production method of L-glufosinate
Production method of L-glufosinate
View all
Owner:ZHEJIANG UNIV

Nitrogen-efficient monocot plants

ActiveUS20070162995A1TransferasesImmunoglobulinsBiotechnologyD-Alanine Transaminase
Nitrogen-efficient monocot plants
Nitrogen-efficient monocot plants
Nitrogen-efficient monocot plants
View all
Owner:BLUE HORSE LABS INC

(S)-alpha-phenethylamine: pyruvate transaminase

InactiveUS6346402B1Valid conversionImprove featuresMicroorganismsTransferasesPropylamineKetone
Relating to an enzyme capable of efficiently converting a ketone compound to an optically active amino compound by transamination, and a process for preparing an optically active amino compound using the enzyme. An (S)-alpha-phenethylamine:pyruvate transaminase, which acts on (S)-alpha-phenethylamine and a ketone compound, thereby catalyzing transamination for forming acetophenone and an amino compound corresponding to the ketone compound; a process for preparing an optically active amino compound using the transaminase; and a method for culturing a microorganism for producing the above transaminase, comprising adding to a medium one or more compounds selected from the group consisting of propylamine, 1-butylamine, 2-butylamine, 2-pentylamine, isopropylamine and isobutylamine as an inducer for the enzyme when a microorganism for producing (S)-alpha-phenethylamine:pyruvate transaminase is cultured.
(S)-alpha-phenethylamine: pyruvate transaminase
(S)-alpha-phenethylamine: pyruvate transaminase
(S)-alpha-phenethylamine: pyruvate transaminase
View all
Owner:KANEKA CORP

Omega-transaminase mutant and encoding gene and preparation method thereof

ActiveCN105441404AImprove thermal stabilityIncrease mutation successBacteriaTransferasesWild typeNucleotide sequencing
The invention discloses an omega-transaminase mutant and an encoding gene and preparation method thereof. The amino acid sequence of the omega-transaminase mutant is shown in SEQ ID NO.2 or SEQ ID NO.4 or SEQ ID NO.6 or SEQ ID NO.8 or SEQ ID NO.10. The nucleotide sequence of the omega-transaminase mutant is shown in SEQ ID NO.1 or SEQ ID NO.3 or SEQ ID NO.5 or SEQ ID NO.7 or SEQ ID NO.9. The invention further discloses an expression box, recombinant plasmid and converter containing the gene. Mutation site prediction is conducted on a wild omega-transaminase mutant through the combination of a temperature factor (B-factor) and the energy optimizing strategy, then site-specific mutagenesis is conducted, and the omega-transaminase mutant is prepared. The thermal stability of the selected mutant is higher than that of wild transaminase.
Omega-transaminase mutant and encoding gene and preparation method thereof
Omega-transaminase mutant and encoding gene and preparation method thereof
Omega-transaminase mutant and encoding gene and preparation method thereof
View all
Owner:ZHEJIANG ORIENT GENE BIOTECH

Disulfide-bond-introduced omega-aminotransferase mutant and application thereof

ActiveCN105950581AIncreased half-inactivation temperatureImprove thermal stabilityTransferasesFermentationArginineHalf-life
The invention provides a disulfide-bond-introduced omega-aminotransferase mutant and application thereof. The amino acid sequence of the omega-aminotransferase mutant is disclosed as SEQ ID NO.1. The omega-aminotransferase mutant is obtained by respectively mutating 131st-site arginine and 134th-site aspartic acid of Aspergillus terreus omega-aminotransferase into cysteines. Compared with the wild type, the half-inactivation temperature of the omega-aminotransferase mutant is enhanced by 1.6 DEG C, the half life at 40 DEG C is 10.4 minutes which is prolonged by 3.5 minutes (50.7%), and the heat stability is greatly enhanced.
Disulfide-bond-introduced omega-aminotransferase mutant and application thereof
Disulfide-bond-introduced omega-aminotransferase mutant and application thereof
Disulfide-bond-introduced omega-aminotransferase mutant and application thereof
View all
Owner:杭州快格科技有限公司

Method for improving fermentability and nutritional property of gluten protein-free dough

ActiveCN104146020AImprove fermentation effectImproved ability to hold gasDough treatmentPre-baking dough treatmentNutritive valuesFermentation
The invention provides a method for improving fermentability and nutritional property of gluten protein-free dough. The method includes the steps of 1) activating glutamic acid transaminase, protease A and yeast; 2) peptizing food in water with temperature 50-100 degrees to be evenly mixed with whole flour free of gluten protein, proteins, starches, sugars and salts; 3) adding the activated glutamic acid transaminase and protease A to the mixture for evenly mixing; 4) adding and stirring the activated yeast in the mixture to form the dough; 5) fermenting the mixture within 40-90mins at the temperature of 36-40 degrees and at the humidity of 70-85%. The method is simple and greatly improves the nutritional property and the fermentability of the gluten protein-free dough at the same time. Thus fermentation size of the dough is increased by 1-3 times, contents of vitamin, protein, dietary fiber, mineral elements and the like are remarkably increased, structures and sizes of fermented products such as breads, steamed breads and steamed sponge cakes are improved, and nutritional value of the fermented products is increased.
Method for improving fermentability and nutritional property of gluten protein-free dough
Method for improving fermentability and nutritional property of gluten protein-free dough
Method for improving fermentability and nutritional property of gluten protein-free dough
View all
Owner:INST OF AGRO FOOD SCI & TECH CHINESE ACADEMY OF AGRI SCI

Production of omega-amino fatty acids

ActiveUS20140178948A1FungiBacteriaAlkane HydroxylaseIodo fatty acid
The invention provides a whole cell catalyst which expresses a recombinant α-dioxygenase or the combination of a recombinant fatty acid reductase and a phosphopantetheinyl transferase phosphopantetheinylating the fatty acid reductase, and which in addition to the α-dioxygenase and / or the combination of fatty acid reductase and phosphopantetheinyl transferase expresses a transaminase, characterized in that the phosphopantetheinyl transferase and / or transaminase is preferably recombinant; and a method for the conversion of a fatty acid, ω-hydroxy fatty acid, ω-oxo fatty acid or a monoester thereof to an amine, comprising oxidation of the fatty acid, ω-hydroxy fatty acid, ω-oxo fatty acid or the monoester thereof to an oxidation product by contacting with an alkane hydroxylase and / or alcohol dehydrogenase, contacting the oxidation product with a phosphopantetheinylated fatty acid reductase or a α-dioxygenase to give an aldehyde, and contacting the aldehyde with a transaminase.
Owner:EVONIK OPERATIONS GMBH

Process for preparing enantiomerically enriched amines

InactiveUS20090117627A1TransferasesTissue cultureEnantiomerKetone
Process for preparing enantiomerically enriched amines
Process for preparing enantiomerically enriched amines
Process for preparing enantiomerically enriched amines
View all
Owner:EVONIK DEGUSSA GMBH

Saccharomyces cerevisiae strain with high yield of ester and low yield of higher alcohol as well as building and application of saccharomyces cerevisiae strain

PendingCN105385615AReduce outputOvercome flavor incongruityFungiHydrolasesEster hydrolaseBio engineering
The invention discloses a saccharomyces cerevisiae strain with high yield of ester and low yield of higher alcohol as well as a building method of the saccharomyces cerevisiae strain, and belongs to the technical field of bioengineering. According to the building method provided by the invention, through completely knocking out an amino acid transaminase gene BAT2 and an ester hydrolase gene IAH1 in an original strain, and selecting a strong promoter PGK1 over-expression alcohol acetyltransferase I gene ATF1 at the same time, the saccharomyces cerevisiae strain with high yield of ester and low yield of higher alcohol is obtained. Compared with a parent strain, other fermentation performances of built recombinant bacteria are not affected, the total quantity of acetic acid ester is obviously increased and reaches 1303.6mg/L, wherein the content of ethyl acetate is 52 times that of the original strain, isoamyl acetate is increased to 73.7mg/L, the content of main higher alcohol is 151.8mg/L and is reduced by 61.4 percent in comparison with that of the original strain. By using the saccharomyces cerevisiae, ester yield is significantly increased while the higher alcohol yield is reduced, the higher requirements of white spirit related fields on yeast are met and the application prospect is wide.
Saccharomyces cerevisiae strain with high yield of ester and low yield of higher alcohol as well as building and application of saccharomyces cerevisiae strain
Saccharomyces cerevisiae strain with high yield of ester and low yield of higher alcohol as well as building and application of saccharomyces cerevisiae strain
Saccharomyces cerevisiae strain with high yield of ester and low yield of higher alcohol as well as building and application of saccharomyces cerevisiae strain
View all
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Transaminase mutant and applications thereof

ActiveCN108384767AIncrease enzyme activityImprove stabilityTransferasesOn/in organic carrierContinuous flowAmino acid
The invention provides a transaminase mutant and applications of the transaminase mutant. The amino acid sequence of the transaminase mutant is the amino acid sequence with mutation as shown in SEQ IDNO:1, the amino acid sites with mutation comprise the T7C+S47C site. For the transaminase mutant with the mutation sites, the enzyme activity and/or stability are/is greatly improved, and the transaminase mutant can be applied in the relatively extreme environment. In addition, the transaminase mutant with the mutation sites can be further prepared into immobilized enzyme through the immobilization technology, the activity and the stability of the immobilized enzyme are relatively high, and the immobilized enzyme can be recycled for a plurality of times, and is suitable for being applied to continuous flow reaction of a packed bed.
Transaminase mutant and applications thereof
Transaminase mutant and applications thereof
Transaminase mutant and applications thereof
View all
Owner:ASYMCHEM LIFE SCI TIANJIN

Producing optically active amino compounds

InactiveUS20020192786A1Efficient and inexpensiveSuitable for useBacteriaSugar derivativesMicroorganismNucleotide
To provide a method for preparing optically active compounds, which mainly contain (R)-amino compounds, by microbial enzymes efficiently and inexpensively; a polypeptide having stereoselective transaminase activity which can be suitably used for the above preparation method; and a DNA encoding the polypeptide. A method for preparing an optically active amino compound, characterized in stereoselectively transaminating by acting a transaminase on an amino group acceptor, a ketone compound in the presence of an amino group donor, a primary amine; a DNA comprising a nucleotide sequence encoding a polypeptide having stereoselective transaminase activity; and a polypeptide having stereoselective transaminase activity obtainable from a culture of a microorganism belonging to the genus Arthrobacter.
Producing optically active amino compounds
Producing optically active amino compounds
Producing optically active amino compounds
View all
Owner:KANEKA CORP

Method for producing multicyclical ring systems carrying amino groups

InactiveUS20120041216A1High activityOrganic chemistryFermentationEnzymeAmination
Method for producing multicyclical ring systems carrying amino groups
Method for producing multicyclical ring systems carrying amino groups
Method for producing multicyclical ring systems carrying amino groups
View all
Owner:EVONIK DEGUSSA GMBH

Transaminase mutant and application thereof

ActiveCN107828751AIncrease enzyme activityChange structureTransferasesGenetic engineeringMutantAsparagine
The invention discloses a transaminase mutant and application thereof. The amino acid sequence of the transaminase mutant is obtained by mutation of an amino acid sequence shown in SEQ ID NO:1, and the mutation at least comprises one of the following mutation sites: the 19th site, the 41st site, the 43rd site, the 72nd site, the 76th site, the 92nd site, the 107th site, the 125th site, the 132nd site, the 226th site, the 292nd site, the 295th site, the 308th site and the 332nd site; the 19th mutation is serine, the 41st mutation is serine, the 43rd mutation is asparagine, and the 72nd glycinemutation is leucine; or the amino acid sequence of the transaminase mutant has mutation sites in a mutated amino acid sequence, and has 80% or more homology with the mutated amino acid sequence. The transaminase mutant disclosed by the invention greatly reduces the cost in industrial production of chiral amine.
Transaminase mutant and application thereof
Transaminase mutant and application thereof
Transaminase mutant and application thereof
View all
Owner:天津凯诺医药科技发展有限公司

Transaminase mutant and application thereof

ActiveCN108048419AReduce dosageHigh catalytic efficiencyFungiBacteriaMutantEnzyme
The invention discloses a transaminase mutant and application thereof. The amino acid sequence of the transaminase mutant is formed after mutation of an amino acid sequence as shown in SEQ ID No. 1, and a mutant amino acid site is one or more selected from a group consisting of F89, K193, P243, V234, I262, Q280, V379, R416, A417 and C418. The transaminase mutant with at least one mutant amino acidsite selected from the above group is greatly improved in enzymatic activity and / or stability.
Transaminase mutant and application thereof
Transaminase mutant and application thereof
Transaminase mutant and application thereof
View all
Owner:ASYMCHEM LIFE SCI TIANJIN

Omega-aminotransferase mutant gene and application thereof

InactiveCN104894148AHigh enzyme productionHigh catalytic efficiencyTransferasesGenetic engineeringPropylamineNucleotide sequencing
The invention discloses an omega-aminotransferase mutant gene and an application thereof, and belongs to the field of the molecular biological technology. The nucleotide sequence of the omega-aminotransferase mutant gene is shown as SEQ ID NO.1. The omega-aminotransferase amino acid sequence embodied by the code of the omega-aminotransferase mutant gene is shown as SEQ ID NO.2. The omega-aminotransferase mutant gene is firstly provided, and the omega- aminotransferase corresponding to the code of the omega-aminotransferase mutant gene has a high enzyme amount, so that the biological catalysis and conversion efficiency is improved in industrial production. The invention further provides the application of the omega-aminotransferase embodied by the code of the omega-aminotransferase mutant gene in preparation of trifluoro-propylamine. The trifluoro-propylamine is added to a buffer solution to serve as the substrate for the reaction, and then products of trifluoromethyl amine compounds are collected from the reaction liquid. The method for preparing the trifluoro-propylamine has the obvious advantages that the reaction conditions are mild, no pollution is caused, and the process is simple.
Omega-aminotransferase mutant gene and application thereof
Omega-aminotransferase mutant gene and application thereof
Omega-aminotransferase mutant gene and application thereof
View all
Owner:ZHEJIANG UNIVERSITY OF SCIENCE AND TECHNOLOGY

System for estimating state of critically ill patient in obstetrical department

InactiveCN101554322AImprove the level of treatmentReduce mortalitySurgeryDiagnostic recording/measuringNervous systemCritically ill
The invention discloses a system for estimating the state of a critically ill patient in an obstetrical department, which comprises an input end, an output end and a data processing module. Firstly, measured heart rate, blood pressure, body temperature, breathing rate, pH, blood HCO-3 concentration, oxygen partial pressure, alveolar arterial blood oxygen tension difference, potassium ion concentration, hematokrit, white cell count, platelet count, fibrinogen, glutamic-oxaloacetic transaminase, albumin, bilirubin, creatinine, blood glucose concentration and nervous system grading data are input the system through the input end; the data processing module evaluates a death risk factor; and at last, the output end directly reflects the result of the patient and the expert suggestion. The invention can not only accurately evaluate the critical degree of the state of the patient and predict the death risk, but also can provide quantitative indexes for changing to a three-class hospital, and is beneficial to improve the treatment level of the critical state of the obstetrical department and lower the death rate of pregnant and lying-in women and perinatal infants.
System for estimating state of critically ill patient in obstetrical department
System for estimating state of critically ill patient in obstetrical department
System for estimating state of critically ill patient in obstetrical department
View all
Owner:陈敦金 +1

Preparation method of soybean protein isolate transparent hydrogel with high gel strength and high swelling property

InactiveCN104855670AIncrease added valueImprove qualityProtein composition from vegetable seedsVegetable proteins working-upFood additiveRefrigerated temperature
A preparation method of soybean protein isolate transparent hydrogel with high gel strength and a high swelling property is provided, comprising: using defatted soybean meal as a raw material, preparing high-purity soybean protein isolate by alkali extraction and acid precipitation; ultrasonic pretreatment, performing ultrasonic treatment on a soybean protein isolate dispersion liquid with concentration of 5% (w/v) for 30 to 90 min; preparing a protein/polysaccharide aggregate solution, mixing chitosan with the soybean protein isolate subjected to the ultrasonic treatment in a mass ratio of 2-7%, performing heat treatment at temperature of 95 DEG C for 30 min, and then cooling to room temperature; adding a glutamine transaminase to the foregoing thermal aggregate solution in a mass ratio of 4-8% (enzyme/protein, m/m); eliminating air bubbles by centrifugation; performing incubation at temperature of 55 DEG C for 4 h; performing enzyme deactivation by heating in water bath at temperature of 95 DEG C for 10 min; performing ice-bath cooling; and placing the mixture in a refrigerator of 4 DEG C for 24 h. The invention is added to food production as a substitute for food additives, and improves an additional value and quality of soybean food, thereby implementing low-carbon sustainable production.
Preparation method of soybean protein isolate transparent hydrogel with high gel strength and high swelling property
View all
Owner:JIANGXI NORMAL UNIV

Aminopherase for producing L-2-aminobutyric acid

ActiveCN105441403AOvercoming conversion rateOvercome concentrationBacteriaTransferasesAminopheraseL-2-Aminobutyric Acid
Aminopherase for producing L-2-aminobutyric acid
Aminopherase for producing L-2-aminobutyric acid
Aminopherase for producing L-2-aminobutyric acid
View all
Owner:湖州颐盛生物科技有限公司

Plants having enhanced yield-related traits and a method for making the same

InactiveCN102224247AClimate change adaptationPlant peptidesAcetic acidGrowth plant
The present invention relates generally to the field of molecular biology and concerns a method for enhancing various economically important yield-related traits in plants. More specifically, the present invention concerns a method for enhancing yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding an ASPAT (Asparatate AminoTransferase) polypeptide. The present invention also concerns plants having modulated expression of a nucleic acid encoding an ASPAT polypeptide, which plants have enhanced yield-related traits relative to control plants. The invention also provides hitherto unknown ASPAT-encoding nucleic acids and constructs comprising the same, useful in performing the methods of the invention. Furthermore, the present invention relates generally to the field of molecular biology and concerns a method for increasing various plant yield-related traits by increasing expression in a plant of a nucleic acid sequence encoding a MYB91 like transcription factor (MYB91 ) polypeptide. The present invention also concerns plants having increased expression of a nucleic acid sequence encoding an MYB91 polypeptide, which plants have increased yield- related traits relative to control plants. The invention additionally relates to nucleic acid sequences, nucleic acid constructs, vectors and plants containing said nucleic acid sequences. Even furthermore, the present invention relates generally to the field of molecular biology and concerns a method for improving various plant growth characteristics by modulating expression in a plant of a nucleic acid encoding a GASA (Gibberellic Acid-Stimulated Arabidopsis). The present invention also concerns plants having modulated expression of a nucleic acid encoding a GASA, which plants have improved growth characteristics relative to corresponding wild type plants or other control plants. The invention also provides constructs useful in the methods of the invention. Yet furthermore, the present invention relates generally to the field of molecular biology and concerns a method for enhancing various economically important yield-related traits in plants. More specifically, the present invention concerns a method for enhancing yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding an AUX / IAA (auxin / indoleacetic acid) polypeptide. The present invention also concerns plants having modulated expression of a nucleic acid encoding IAA polypeptide, which plants have enhanced yield-related traits relative to control plants. The invention also provides constructs comprising AUX / IAA-encoding nucleic acids, useful in performing the methods of the invention.
Plants having enhanced yield-related traits and a method for making the same
Plants having enhanced yield-related traits and a method for making the same
Plants having enhanced yield-related traits and a method for making the same
View all
Owner:BASF PLANT SCI GMBH

Lactobacillus plantarum with high aminotransferase activity and application of lactobacillus plantarum in cheese

ActiveCN103602611APromote growthIncrease vitalityBacteriaMicroorganism based processesMicroorganismDecomposition
The invention discloses lactobacillus plantarum which was collected in China General Microbiological Culture Collection Center on 25th, Sep., 2013. The collection number is CGMCC No.8242, and the collection address is No. 3, 1 Beichen West road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences. The lactobacillus plantarum provided by the invention has high activities of peptidase and aminotransferase. When the lactobacillus plantarum used as an auxiliary leavening agent is added into a cheddar cheese model, contents of water-soluble nitrogen, 5% PTA-SN and 12% TCA-SN in cheese are higher, protein decomposition degree can be improved effectively, flavoring characteristics of aged cheddar cheese can be formed in a short period of time, sensory scores of nut and sulphur taste of the aged cheese in the cheddar cheese model are increased, ripening period of cheddar cheese is shortened and the cost of storage can be saved.
Lactobacillus plantarum with high aminotransferase activity and application of lactobacillus plantarum in cheese
Lactobacillus plantarum with high aminotransferase activity and application of lactobacillus plantarum in cheese
Lactobacillus plantarum with high aminotransferase activity and application of lactobacillus plantarum in cheese
View all
Owner:JIANGNAN UNIV

Immobilized transaminase and application of immobilized transaminase in synthesis of sitagliptin intermediate

ActiveCN105219745AImprove bindingMild responseChemical industryTransferasesEpoxyDerivatization
The invention provides immobilized transaminase. The immobilized transaminase is obtained by fixing transaminase, with histidine tag, derived from Mycobacterium vanbaalenii PYR-1 onto an enzyme immobilization carrier; the enzyme immobilization carrier is obtained by derivatization of epoxy resin through IDA (imino diethyl acetic acid) and cobalt chloride or derivatization of ionic chelate resin through cobalt chloride. The immobilized transaminase has the advantages of firmness in combination, low enzyme activity loss, simplicity in separation and high reusability; low cost of an asymmetric conversion process, mild reaction conditions, environment friendliness, simplicity and convenience in operation, easiness in industrial expanding and promising industrial application prospect are realized.
Immobilized transaminase and application of immobilized transaminase in synthesis of sitagliptin intermediate
Immobilized transaminase and application of immobilized transaminase in synthesis of sitagliptin intermediate
Immobilized transaminase and application of immobilized transaminase in synthesis of sitagliptin intermediate
View all
Owner:ABIOCHEM BIOTECH CO LTD

Transaminase mutant and application thereof

ActiveCN110592042AReduce dosageChange structureTransferasesFermentationAfter treatmentMutant
The invention discloses a transaminase mutant and application thereof. An amino acid sequence of the transaminase mutant is an amino acid sequence obtained by mutation of an amino acid sequence shownin SEQ ID NO:1, and mutation at least comprises one of the following mutation site combinations: T7C+S47C, Q78C+A330C, V137C+G313C, A217C+Y252C and L295C+C328C; or the amino acid sequence of the transaminase mutant is an amino acid sequence which has a mutation site in a mutant amino acid sequence and has 80% homology or above with the mutant amino acid sequence. The transaminase mutant realizes change of protein structure and functions, reduces enzyme dose, increased the ee value of the product and reduces after treatment difficulty, so that the transaminase mutant can be suitable for industrial production.
Transaminase mutant and application thereof
Transaminase mutant and application thereof
Transaminase mutant and application thereof
View all
Owner:ASYMCHEM LAB TIANJIN

Method to increase the yield and improve purification of products from transaminase reactions

InactiveUS7588923B2Improve applicabilityHigh activityFermentationKetoneChiral amine
Method to increase the yield and improve purification of products from transaminase reactions
Method to increase the yield and improve purification of products from transaminase reactions
Method to increase the yield and improve purification of products from transaminase reactions
View all
Owner:RICHMOND CHEM CORP

Method for stabilizing aminotransferase activity in a biological fluid

InactiveUS6465202B1Easy to collectHigh activityMicrobiological testing/measurementBiological material analysisAminotransferase activityLiver toxicity
Method for stabilizing aminotransferase activity in a biological fluid
Method for stabilizing aminotransferase activity in a biological fluid
Method for stabilizing aminotransferase activity in a biological fluid
View all
Owner:BIOSAFE LAB

Transaminase derived from actinomyces, mutant, recombinant bacteria and application

ActiveCN108823179AImprove conversion rateLow priceBacteriaTransferasesEscherichia coliAlcohol
The invention discloses transaminase derived from actinomyces, a mutant, recombinant bacteria and application. A biological preparation method of R-3-aminobutanol, provided by the invention, takes butanone alcohol as a raw material the price is cheap. A large amount of needed recombinant transaminase can be prepared through constructing escherichia coli genetic engineering bacteria and then fermenting, and is relatively easy to obtain and cheap. Reaction is one-pot-boiling type reaction; after a substrate and an enzyme are added, the reaction is started and a final product R-3-aminobutanol isdirectly obtained; the industrial cost is low. Compared with a wild type, an actinomyces transaminase mutant provided by the invention has better catalytic activity. Under an optimal system, the conversion rate on the 100mM substrate reach 90 percent and the ee value reaches 99.9 percent; the conversion rate on the 500mM substrate reach 78 percent and the ee value reaches 99.9 percent; compared with the wild type, the actinomyces transaminase mutant has the advantage that the conversion rates on the substrates are respectively improved by 12 percent to 25 percent.
Transaminase derived from actinomyces, mutant, recombinant bacteria and application
Transaminase derived from actinomyces, mutant, recombinant bacteria and application
View all
Owner:ZHEJIANG UNIV OF TECH

Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof

ActiveCN101837065AExact therapeutic effectLiver function indicators improved in an all-round wayDigestive systemImmunological disordersDiseaseFiltration
The invention discloses a medicine with anti-inflammatory, anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof, solving the technical problems of improving curative effect of treatment on hepatitis and tumour diseases. The medicine of the invention comprises the following traditional Chinese medicine materials by weight proportion: 800-1200g of sculellaria barbata, 400-600g of dedyotis diffusa and 400-600g of Chinese lobelia. The preparation method thereof includes: the raw materials crude slices are decocted and concentrated, ethyl alcohol is added and standing at room temperature is carried out, filtering is carried out, pH is adjusted to be 8.0, filtrate is recovered until no ethyl alcohol is remained, then ethyl alcohol is added for standing, filtrate is recovered until no ethyl alcohol is remained, pH value is adjusted to be 7.5, and filtration is carried out. Compared with the prior art, the invention has the advantages that sculellaria barbata, dedyotis diffusa and Chinese lobelia have the efficacies of clearing heat and detoxicating, eliminating blood stasis for analgesic and inducing diuresis for reducing edema, combination of the three not only can realize anti-inflammatory, anti-hepatitis, anti-tumour functions but also can improve organism immunity, liver and spleen can be obviously shrunk for hepatitis patients, and transaminase and other liver function indexes can be improved in an all-round way.
Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof
Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof
Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof
View all
Owner:粤北人民医院

Recombinant transaminase as well as preparation method and application of recombinant transaminase

ActiveCN106801043AStrong specificityHigh catalytic activityOrganic chemistryBacteriaRegioselectivityMutant
The invention discloses recombinant transaminase as well as a preparation method and application of the recombinant transaminase. An amino acid sequence of a high-activity recombinant transaminase mutant is as shown in SEQ ID NO.2 and a coding gene is as shown in SEQ ID NO.1. The method for preparing the recombinant transaminase compries the steps of fermenting and cultivating a gene engineering bacterium containing the coding gene, and collecting and preparing the recombinant transaminase. The recombinant transaminase is applied to asymmetric synthesis of a chiral amine compound, and particularly is applied to synthesis of a sitagliptin midbody (R)-3-amino-4-(2,4,5-trifluoromethyl phenyl)-methyl butyrate. The related transaminase has excellent stereoselectivity, regioselectivity and catalytic activity, the catalytic reaction is mild, the reaction conversion rate and the yield of a product are high, and the recombinant transaminase has relatively good application prospect.
Recombinant transaminase as well as preparation method and application of recombinant transaminase
Recombinant transaminase as well as preparation method and application of recombinant transaminase
Recombinant transaminase as well as preparation method and application of recombinant transaminase
View all
Owner:JIANGSU ALPHA PHARM CO LTD

Popular searches

Microbial enzymes A-DNA Receptor for activated C kinase 1 Stereoselectivity Transaminase Optically active Chirality Dehydrogenase Glutamate dehydrogenase Raw material
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap